Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1996

Caffeine clearance in patients with primary biliary cirrhosis

Frantisek Perlik, Martin Gilar, Marie Brodanova

Med Sci Monit 1996; 2(4): CR457-460 :: ID: 499946


The clinical value and the sensitivity of saliva caffeine clearance measurement was evaluated as an indicator of liver metabolic capacity in patients with primary biliary cirrhosis (PBC). Saliva test was performed in 12 female patients with PBC and 8 healthy female volunteers. After a 48 hour caffeine exclusion period two doses of 140 mg of caffeine separated by a 4 hour interval were administered orally. Saliva samples were taken 6 and 14 hours later. Caffeine concentrations were measured by high-performance liquid chromatography. Pharmacokinetic parameters were calculated by the fitting procedure of the Bayesian feedback method. There was a significant increase of caffeine half-life in patients with PBC with the mean (SD) value of 5.47 (1.33) hours as compared to that in healthy controls - 4.5 (0.69) hours. The correlation between the pharmacokinetic parameters of caffeine (half-life, clearance and volume of distribution) was statistically significant (p < 0.05) both with the prothrombin ratio and staging, based on morphologic findings in the PBC group. There was no significant correlation neither between the pharmacokinetic parameters of caffeine and conventional liver function tests, nor between the pharmacokinetic parameters and galactose elimination capacity (GEC). Our results suggest that caffeine clearance, like GEC, quantitates a very particular enzymatic reaction which may not be representative for the functional capacity of the entire organ. Thus, a simplified caffeine clearance test represents a helpful additional criterion for the assessment of hepatic function in patients with PBC.

Keywords: primary biliary cirrhosis, caffeine clearance, Bayesian estimate

Add Comment 0 Comments

387 0


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

05 Jun 2023 : Laboratory Research  

Comparison of Composite Resin (Duo-Shade) Shade Guide with Vita Ceramic Shades Before and After Chemical an...

Med Sci Monit In Press; DOI: 10.12659/MSM.940949  

01 Jun 2023 : Clinical Research  

Root Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940472  

01 Jun 2023 : Clinical Research  

Internal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease

Med Sci Monit In Press; DOI: 10.12659/MSM.940873  

01 Jun 2023 : Clinical Research  

Effectiveness of Needle Aspiration versus Surgical Excision for Symptomatic Synovial Cysts of the Hip: A Si...

Med Sci Monit In Press; DOI: 10.12659/MSM.940187  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750